EpiPen maker overcharged government for $1B, says watchdog
By BENJAMIN SIEGEL
May 31, 2017, 8:30 PM ETThe company behind the lifesaving EpiPen epinephrine injectors may have overcharged the federal government by more than $1 billion, according to a new estimate from the Department of Health and Human Services.
In a letter to Sen. Chuck Grassley, R-Iowa, the chairman of the Senate Judiciary Committee, the HHS inspector general revealed that Mylan, the pharmaceutical company behind the devices, may have bilked taxpayers out of $1.27 billion over 10 years by incorrectly classifying its signature product under a government rebate program.
Categorizing EpiPens as a generic drug instead of a brand-name product allowed the company to provide Medicaid less in rebates, leaving taxpayers with a bigger bill.
<..snip..>
http://abcnews.go.com/Politics/epipen-maker-overcharged-government-1b-watchdog/story?id=47758340
